Rare gene glitch may hold clues for schizophrenia – 2
Narrator: This is NIH Health Matters. I’m Joe Balintfy. Scientists have identified a rare genetic glitch that could help improve treatments for schizophrenia. Dr. Jonathan Sebat at the University of California San Diego led a study team that found mutations in a gene that controls part of the system for a brain chemical called a neuropeptide.
Sebat: Neuropeptides are interesting because they affect neurons, help to regulate gene expression, blood flow, and the formation of synapses, for example.
Narrator: A neuropeptide acts as a chemical messenger in the brain.
Sebat: Our findings established a link between the neuropeptide receptor VIPR2 and schizophrenia.
Narrator: For more information on the VIPR2 gene and schizophrenia, visit www.nimh.nih.gov. Health Matters is produced by the National Institutes of Health, part of the U.S. Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.